Fragile X Syndrome: The GABAergic System and Circuit Dysfunction

被引:135
作者
Paluszkiewicz, Scott M. [1 ,2 ]
Martin, Brandon S. [1 ,2 ]
Huntsman, Molly M. [1 ]
机构
[1] Childrens Natl Med Ctr, Ctr Neurosci Res, Washington, DC 20010 USA
[2] Georgetown Univ Med Ctr, Interdisciplinary Program Neurosci, Washington, DC USA
关键词
Inhibition; Fragile X mental retardation protein; Synapse; Developmental disorder; Autism spectrum disorders; Cerebral cortex; Amygdala; MENTAL-RETARDATION PROTEIN; GABA(A) RECEPTOR SUBUNIT; FMR1 KNOCKOUT MICE; HIPPOCAMPAL PYRAMIDAL CELLS; RAT BASOLATERAL AMYGDALA; SHORT-TERM TREATMENT; BARREL FIELD CORTEX; FAST-SPIKING CELLS; MOUSE MODEL; INHIBITORY CIRCUITS;
D O I
10.1159/000329420
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Fragile X syndrome (FXS) is a neurodevelopmental disorder characterized by intellectual disability, sensory hypersensitivity, and high incidences of autism spectrum disorders and epilepsy. These phenotypes are suggestive of defects in neural circuit development and imbalances in excitatory glutamatergic and inhibitory GABAergic neurotransmission. While alterations in excitatory synapse function and plasticity are well-established in Fmr1 knockout (KO) mouse models of FXS, a number of recent electrophysiological and molecular studies now identify prominent defects in inhibitory GABAergic transmission in behaviorally relevant forebrain regions such as the amygdala, cortex, and hippocampus. In this review, we summarize evidence for GABAergic system dysfunction in FXS patients and Fmr1 KO mouse models alike. We then discuss some of the known developmental roles of GABAergic signaling, as well as the development and refinement of GABAergic synapses as a framework for understanding potential causes of mature circuit dysfunction. Finally, we highlight the GABAergic system as a relevant target for the treatment of FXS. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:349 / 364
页数:16
相关论文
共 190 条
[101]   Molecular mechanisms of interaction between the neuroprotective substance riluzole and GABAA-receptors [J].
Jahn, K. ;
Schlesinger, F. ;
Jin, L. J. ;
Dengler, R. ;
Bufler, J. ;
Krampfl, K. .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 378 (01) :53-63
[102]   GABAergic cell subtypes and their synaptic connections in rat frontal cortex [J].
Kawaguchi, Y ;
Kubota, Y .
CEREBRAL CORTEX, 1997, 7 (06) :476-486
[103]   Expression of group one metabotropic glutamate receptor subunit mRNAs in neurochemically identified neurons in the rat neostriatum, neocortex, and hippocampus [J].
Kerner, JA ;
Standaert, DG ;
Penney, JB ;
Young, AB ;
Landwehrmeyer, GB .
MOLECULAR BRAIN RESEARCH, 1997, 48 (02) :259-269
[104]   Time-matched pre- and postsynaptic changes of GABAergic synaptic transmission in the developing mouse superior colliculus [J].
Kirischuk, S ;
Jüttner, R ;
Grantyn, R .
JOURNAL OF PHYSIOLOGY-LONDON, 2005, 563 (03) :795-807
[105]   Cell type- and input-specific differences in the number and subtypes of synaptic GABAA receptors in the hippocampus [J].
Klausberger, T ;
Roberts, JDB ;
Somogyi, P .
JOURNAL OF NEUROSCIENCE, 2002, 22 (07) :2513-2521
[106]   Developmental profile of GABAA-mediated synaptic transmission in pyramidal cells of the somatosensory cortex [J].
Kobayashi, Masayuki ;
Hamada, Tomohiro ;
Kogo, Mikihiko ;
Yanagawa, Yuchio ;
Obata, Kunihiko ;
Kang, Youngnam .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2008, 28 (05) :849-861
[107]   Pharmacological characterization of GABAA receptors in taurine-fed mice [J].
L'Amoreaux, William J. ;
Marsillo, Alexandra ;
El Idrissi, Abdeslem .
JOURNAL OF BIOMEDICAL SCIENCE, 2010, 17
[108]  
LAURIE DJ, 1992, J NEUROSCI, V12, P4151
[109]   The emotional brain, fear, and the amygdala [J].
LeDoux, J .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2003, 23 (4-5) :727-738
[110]   Cortical inhibitory neurons and schizophrenia [J].
Lewis, DA ;
Hashimoto, T ;
Volk, DW .
NATURE REVIEWS NEUROSCIENCE, 2005, 6 (04) :312-324